🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Resilient pathways for drug discovery in challenging times

Trends in Pharmacological Sciences(2025)10.1016/j.tips.2025.10.006Source: DataRank Database

Resilient pathways for drug discovery in challenging times is a research paper published in Trends in Pharmacological Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 0.74)OA: greenTopics (23)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Barbara S. Slusher ORCID,Sean Ekins ORCID

Live enrichment

PubMed:41309431 OpenAlex:https://openalex.org/W4416696104

National Institute of Neurological Disorders and Stroke

Grant: 1SB1NS135733-01

National Institute of Neurological Disorders and Stroke

Grant: R01AG068130

National Institute of Neurological Disorders and Stroke

Grant: R25NS129110

National Institute of Neurological Disorders and Stroke

Grant: R01AG084728

National Institute of Neurological Disorders and Stroke

Grant: R01AG078181

National Institute of Neurological Disorders and Stroke

Grant: P30MH075673

National Institute of Neurological Disorders and Stroke

Grant: R56MH135895

National Institute of Neurological Disorders and Stroke

Grant: R01AI155602

National Institute of Neurological Disorders and Stroke

Grant: R01CA282475

National Institute of Neurological Disorders and Stroke

Grant: R01NS093416

National Institute of Neurological Disorders and Stroke

Grant: R01AG065168

National Institute of Environmental Health Sciences

Grant: R44ES033855

National Institute of Environmental Health Sciences

Grant: 2R44NS107079-02A1

NINDS NIH HHS

Grant: R44 NS107079

NINDS NIH HHS

Grant: SB1 NS135733

Johns Hopkins University

Novo Nordisk Fonden

Crohn's and Colitis Foundation

NIH

National Science Foundation

FWCI

0.74

Citation Percentile

0.8%

Citation Trend

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13234793/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13234793/

publisherhttps://api.elsevier.com/content/article/PII:S0165614725002305?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0165614725002305?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.tips.2025.10.006

Fields of Study

Computational Drug Discovery MethodsBiotechnology and Related FieldsCell Image Analysis TechniquesDrug DiscoveryHumansUnited StatesArtificial IntelligenceNational Institutes of Health (U.S.)

MeSH Terms

Artificial IntelligenceHumansNational Institutes of Health (U.S.)United StatesDrug Discovery

Keywords

CommercializationDrug discoveryScientific discoveryPublic healthDrugMEDLINENih FundingAcademic Drug Discovery CentersPolitical ConstraintsSmall Biopharma Drug Discovery